Some newer
antipsychotic agents are associated with
weight gain in humans and a hyperphagic response to
intralipid solutions in rodents. To examine the possible contribution of
serotonin (5-HT) and
histamine (H) receptor blockade in
antipsychotic-associated
hyperphagia, rats were trained to drink a palatable, high-calorie fat
emulsion (10%
intralipid) during 30-min sessions and were tested following pretreatment with
mepyramine (
H1 receptor antagonist),
metergoline (5-HT(1/2) receptor antagonist),
cyproheptadine (H1 and 5-HT(2A/2B/2C) and
muscarinic receptor antagonist),
SB 242084 (
5-HT2C receptor antagonist) and an SB 242084-mepyramine combination. Total intake and ingestive behaviour microstructure were measured.
Mepyramine (10 mg/kg) reduced intake, as did
metergoline (3.0 mg/kg).
Cyproheptadine (0.1-1.0 mg/kg) increased intake and microstructural analysis suggests that this was due to increased numbers of clusters of licking.
SB 242084 (3 mg/kg) reduced intake, either when administered alone, or in combination with
mepyramine (1 mg/kg). In conclusion, simple antagonism of either H1 (
mepyramine) or 5-HT(1/2) receptors (
metergoline) alone was not sufficient to increase intake. Furthermore, combined blockade of H1 and 5-HT2C receptors (
SB 242084 and
mepyramine) was also insufficient to produce
hyperphagia. Conversely, simultaneous blockade of H1, 5-HT(2A/2C) and
muscarinic receptors (
cyproheptadine) led to a substantial
hyperphagia and pattern of ingestive behaviour that was similar to that previously observed with some newer
antipsychotic agents.